Search details
1.
Acknowledging Patient Heterogeneity in Economic Evaluations in Schizophrenia: A Systematic Review.
Value Health
; 25(1): 147-156, 2022 01.
Article
in English
| MEDLINE | ID: mdl-35031093
2.
A review of economic evaluations of health care for people at risk of psychosis and for first-episode psychosis.
BMC Psychiatry
; 22(1): 126, 2022 02 17.
Article
in English
| MEDLINE | ID: mdl-35177010
3.
Development of a cost of illness inventory questionnaire for children with autism spectrum disorder in South Asia.
BMC Health Serv Res
; 22(1): 1137, 2022 Sep 08.
Article
in English
| MEDLINE | ID: mdl-36076224
4.
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Lancet Oncol
; 22(5): 690-701, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33798493
5.
Long-term clinical and cost-effectiveness of collaborative care (versus usual care) for people with mental-physical multimorbidity: cluster-randomised trial.
Br J Psychiatry
; 213(2): 456-463, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29761751
6.
Second-line FOLFOX chemotherapy for advanced biliary tract cancer - Authors' reply.
Lancet Oncol
; 22(7): e288-e289, 2021 07.
Article
in English
| MEDLINE | ID: mdl-34197751
7.
Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial.
Lancet
; 383(9926): 1395-403, 2014 Apr 19.
Article
in English
| MEDLINE | ID: mdl-24508320
8.
Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature.
Pharmacoeconomics
; 2024 Apr 27.
Article
in English
| MEDLINE | ID: mdl-38676871
9.
Development and evaluation of a de-escalation training intervention in adult acute and forensic units: the EDITION systematic review and feasibility trial.
Health Technol Assess
; 28(3): 1-120, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38343036
10.
Valuing the economic benefits of complex interventions: when maximising health is not sufficient.
Health Econ
; 22(3): 258-71, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-22308053
11.
Factors Limiting Subgroup Analysis in Cost-Effectiveness Analysis and a Call for Transparency.
Pharmacoeconomics
; 40(2): 149-156, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34713422
12.
Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme.
Front Psychiatry
; 13: 886407, 2022.
Article
in English
| MEDLINE | ID: mdl-35722590
13.
Discrete choice experiment to investigate preferences for psychological intervention in cardiac rehabilitation.
BMJ Open
; 12(11): e062503, 2022 11 07.
Article
in English
| MEDLINE | ID: mdl-36343991
14.
Health State Values of Deaf British Sign Language (BSL) Users in the UK: An Application of the BSL Version of the EQ-5D-5L.
Appl Health Econ Health Policy
; 18(4): 547-556, 2020 08.
Article
in English
| MEDLINE | ID: mdl-31942693
15.
Protocol for the economic evaluation of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression.
BMJ Open
; 10(9): e035552, 2020 09 10.
Article
in English
| MEDLINE | ID: mdl-32912974
16.
Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification system.
Value Health
; 12(6): 1026-34, 2009 Sep.
Article
in English
| MEDLINE | ID: mdl-19473335
17.
Outcome measurement in clinical genetics services: a systematic review of validated measures.
Value Health
; 11(3): 497-508, 2008.
Article
in English
| MEDLINE | ID: mdl-18489673
18.
A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine.
Value Health
; 11(4): 549-62, 2008.
Article
in English
| MEDLINE | ID: mdl-18179662
19.
Cost-effectiveness of cardiac rehabilitation: a systematic review.
Heart
; 104(17): 1403-1410, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29654096
20.
The COMMAND trial of cognitive therapy for harmful compliance with command hallucinations (CTCH): a qualitative study of acceptability and tolerability in the UK.
BMJ Open
; 8(6): e021657, 2018 06 15.
Article
in English
| MEDLINE | ID: mdl-29909374